Cells need to adjust to changes in the external environment, to respond to signals from neighboring cells. Binding of extracellular
signaling molecules to cell‐surface receptors such as G protein‐coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs) activates
limited number of signaling pathways. These pathways do not simply transmit, but they also process, encode and integrate internal and
external signals. MAPK (mitogen‐activated protein kinase) signal transduction pathways regulate diverse cellular processes ranging from
proliferation and differentiation to apoptosis [
1]. Five families of MAPKs have
been defined in mammalian cells: extra cellular signal‐regulated kinases (ERK1 and ERK2); c‐Jun N‐terminal kinases (JNK1, JNK2 and JNK3);
P38 kinase isozymes (P38α, P38β, P38γ and P38δ); ERK3/ERK4; and ERK5. By and large, activation of ERKs
has been linked to cell survival, whereas JNKs and P38 kinases are linked to induction of apoptosis. This dichotomy, however, is an
oversimplification, and the actual roles of each MAPK cascade are highly cell‐type specific and context‐dependent
[
2].
In the processes of cellular signaling, protein‐protein interactions play a central role. Protein kinases are enzymes that covalently
attach phosphate to the side chain of serine, threonine, or tyrosine of specific proteins inside cells and protein phosphatases remove
the phosphates that were transferred to the protein substrate by the kinase. In this manner, the action of MAPKs and protein phosphatases
reciprocally and rapidly alter the behavior of cells as they respond to changes in their environment
[
2]. A MAPKKK that is activated by extracellular stimuli phosphorylates a MAPKK on
its serine and threonine residues. This MAPKK activates a MAPK through phosphorylation of its serine and tyrosine residues. The
activated MAPKs, in turn, phosphorylate specific serines and threonines of target protein substrates and regulate cellular activities
ranging from gene expression, mitosis, movement, metabolism, and programmed death [
2].
Based on the information's given in JNK and P38 pathway diagrams deposited in the Science's STKE (Signal Transduction
Knowledge Environment) database [
3,
4],
we have drawn the diagram () to depict ERK5, JNK and P38 Kinase cascades with cross‐talks.
ERK5 is a MAP Kinase regulated by a wide range of mitogens and cellular stresses. The potentially crucial role of ERK5 in cancers and
heart diseases make this cascade highly attractive for the development of new therapeutic strategies to treat pathological conditions
that are resistant to current therapies [
5]. The JNKs consist of three isoforms:
JNK1 and JNK2 are the products of alternative splicing of a single gene and are expressed in many tissues, but JNK3 is specifically
expressed in neuronal tissue brain. Members of the JNK family play crucial roles in regulating responses to environmental stress,
radiation, and growth factors, and in neural development, inflammation, and apoptosis [
6].
Four isoforms of P38 MAP kinase: P38α, P38β, P38γ and P38δ have been identified. The P38 MAPKs play an
important role in asthma and autoimmunity in humans and are activated by numerous physical and chemical stresses, including hormones, UV
irradiation, ischemia, cytokines including interleukin‐1 and tumor necrosis factor, osmotic shock and heat shock
[
7].